VUI Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA.
VUI Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA.
Eur Urol. 2017 Nov;72(5):677-685. doi: 10.1016/j.eururo.2017.04.029. Epub 2017 May 6.
Retzius-sparing (posterior) robot-assisted radical prostatectomy (RARP) may expedite postoperative urinary continence recovery.
To compare the short-term (≤3 mo) urinary continence (UC), urinary function (UF), and UF-related bother outcomes of posterior RARP compared with standard anterior approach RARP.
DESIGN, SETTING, AND PARTICIPANTS: A total of 120 patients aged 40-75 yr with low-intermediate-risk prostate cancer (per the National Comprehensive Cancer Network guidelines) underwent primary RARP at a tertiary care institution.
Eligible men were randomized to receive either posterior (n=60) or anterior (n=60) RARP.
Primary outcome was UC (defined as 0 pads/one security liner per day) 1 week after catheter removal. Secondary outcomes were short-term (≤3 mo) UC recovery, and UF and UF-related bother scores (measured by the International Prostate Symptom Score [IPSS] and IPSS quality-of-life scores, respectively) assessed at 1 and 2 wk, and 1 and 3 mo following catheter removal. Continence outcomes were objectively verified using 24-hr pad weights. UC recovery was analyzed using Kaplan-Meier method and Cox proportional hazards regression; UF and UF-related bother outcomes were compared using linear generalized estimating equations (GEEs). Perioperative complications, positive surgical margin, and biochemical recurrence-free survival (BCRFS) represent secondary outcomes reported in the study.
Compared with 48% in the anterior arm, 71% men undergoing posterior RARP were continent 1 wk after catheter removal (p=0.01); corresponding median 24-h pad weights were 25 and 5g (p=0.001). Median time to continence in posterior versus anterior RARP was 2 and 8 d postcatheter removal, respectively (log-rank p=0.02); results were confirmed on multivariable regression analyses. GEE analyses showed that UF-related bother (but not UF) scores were significantly lower in the posterior versus anterior RARP group at 1 wk, 2 wk, and 1 mo on GEE analyses. Incidence of postoperative complications (12% anterior vs 18% posterior) and probability of BCRFS (0.91 vs 0.91) were comparable in the two arms.
In this single-center randomized study, the Retzius-sparing approach of RARP resulted in earlier recovery of UC and lower UF-related bother compared with standard RARP. These results require long-term validation and reproduction by other centers, as well as studies on men with high-risk localized disease.
In our hands, men with low-intermediate-risk prostate cancer undergoing Retzius-sparing robot-assisted radical prostatectomy (RARP) had earlier recovery of urinary continence and lower urinary function-related bother than those undergoing standard RARP.
保留耻骨后间隙(后方)机器人辅助根治性前列腺切除术(RARP)可能会加速术后尿控的恢复。
比较后方 RARP 与标准前入路 RARP 在短期(≤3 个月)尿控(UC)、尿功能(UF)和 UF 相关困扰结果方面的差异。
设计、地点和参与者:总共 120 名年龄在 40-75 岁之间、患有低-中危前列腺癌(根据国家综合癌症网络指南)的患者在一家三级医疗机构接受了初次 RARP。
符合条件的男性被随机分配接受后方(n=60)或前方(n=60)RARP。
主要结局为导管拔除后 1 周时 UC(定义为 0 片/日一片安全垫)。次要结局为短期(≤3 个月)UC 恢复情况,以及 UF 和 UF 相关困扰评分(分别通过国际前列腺症状评分[IPSS]和 IPSS 生活质量评分进行测量),在导管拔除后 1、2、1 和 3 周进行评估。使用 24 小时尿垫重量客观验证控尿结果。使用 Kaplan-Meier 方法和 Cox 比例风险回归分析 UC 恢复情况;使用线性广义估计方程(GEE)比较 UF 和 UF 相关困扰结局。围手术期并发症、切缘阳性和生化无复发生存率(BCRFS)是该研究中报告的次要结局。
与前方组的 48%相比,接受后方 RARP 的 71%男性在导管拔除后 1 周时控尿(p=0.01);相应的中位 24 小时尿垫重量分别为 25 和 5g(p=0.001)。后方与前方 RARP 组的中位控尿时间分别为导管拔除后 2 和 8 天(对数秩检验,p=0.02);多变量回归分析结果一致。GEE 分析显示,在 GEE 分析中,在后入路与前入路 RARP 组中,UF 相关困扰(但不是 UF)评分在 1 周、2 周和 1 个月时显著更低。术后并发症发生率(前方组 12% vs 后方组 18%)和 BCRFS 概率(0.91 vs 0.91)在两组间相当。
在这项单中心随机研究中,与标准 RARP 相比,保留耻骨后间隙的 RARP 可更早恢复尿控,UF 相关困扰也更低。这些结果需要其他中心的长期验证和复制,以及对高危局限性疾病患者的研究。
在我们的手中,接受保留耻骨后间隙的机器人辅助根治性前列腺切除术(RARP)的低-中危前列腺癌患者,与接受标准 RARP 的患者相比,尿控恢复更早,UF 相关困扰更小。